BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 3887403)

  • 1. Rationale for bone marrow transplantation in the treatment of autoimmune diseases.
    Ikehara S; Good RA; Nakamura T; Sekita K; Inoue S; Oo MM; Muso E; Ogawa K; Hamashima Y
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2483-7. PubMed ID: 3887403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation.
    Ikehara S; Yasumizu R; Inaba M; Izui S; Hayakawa K; Sekita K; Toki J; Sugiura K; Iwai H; Nakamura T
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3306-10. PubMed ID: 2654943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation.
    Ikehara S; Nakamura T; Sekita K; Muso E; Yasumizu R; Ohtsuki H; Hamashima Y; Good RA
    Prog Clin Biol Res; 1987; 229():131-46. PubMed ID: 3299389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation: a new strategy for intractable diseases.
    Ikehara S
    Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal stem cells in autoimmune-prone mice are responsible for premature thymic involution.
    Nakamura T; Ikehara S; Good RA; Inoe S; Sekita K; Furukawa F; Tanaka H; Oo MM; Hamashima Y
    Thymus; 1985; 7(3):151-60. PubMed ID: 4035725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.
    Ishida T; Inaba M; Hisha H; Sugiura K; Adachi Y; Nagata N; Ogawa R; Good RA; Ikehara S
    J Immunol; 1994 Mar; 152(6):3119-27. PubMed ID: 8144907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation for autoimmune diseases.
    Ikehara S
    Acta Haematol; 1998; 99(3):116-32. PubMed ID: 9587393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
    Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
    J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
    Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
    Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
    Kushida T; Inaba M; Takeuchi K; Sugiura K; Ogawa R; Ikehara S
    Blood; 2000 Mar; 95(5):1862-8. PubMed ID: 10688849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice.
    Wang B; Yamamoto Y; El-Badri NS; Good RA
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3012-6. PubMed ID: 10077628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice.
    Kushida T; Inaba M; Hisha H; Ichioka N; Esumi T; Ogawa R; Iida H; Ikehara S
    Blood; 2001 May; 97(10):3292-9. PubMed ID: 11342461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation.
    Ikehara S; Ohtsuki H; Good RA; Asamoto H; Nakamura T; Sekita K; Muso E; Tochino Y; Ida T; Kuzuya H
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7743-7. PubMed ID: 3906651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of acute graft-versus-host-like reaction in [MRL/lpr----MRL/+] chimeric mice using MRL/lpr-Thy-1. 1 congenic mice.
    Nakagawa T; Nagata N; Hosaka N; Inaba M; Yasumizu R; Ogawa R; Ikehara S
    Cell Immunol; 1991 Oct; 137(1):189-99. PubMed ID: 1679378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of thymic abnormalities in autoimmune-prone (NZW x BXSB) F1 mice.
    Adachi Y; Inaba M; Inaba K; Than S; Kobayashi Y; Ikehara S
    Immunobiology; 1993 Aug; 188(4-5):340-54. PubMed ID: 8244442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful liver allografts in mice by combination with allogeneic bone marrow transplantation.
    Nakamura T; Good RA; Yasumizu R; Inoue S; Oo MM; Hamashima Y; Ikehara S
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4529-32. PubMed ID: 3520575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of tolerance induction using triple chimeric mice: major histocompatibility complex-disparate thymus, hemopoietic cells, and microenvironment.
    Cui W; Hosaka N; Miyake T; Wang X; Guo K; Cui Y; Li Q; Song C; Feng W; Li Q; Takaki T; Nishida T; Inaba M; Ikehara S
    Transplantation; 2008 Apr; 85(8):1151-8. PubMed ID: 18431236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus.
    Matsumoto K; Yoshikai Y; Asano T; Himeno K; Iwasaki A; Nomoto K
    J Exp Med; 1991 Jan; 173(1):127-36. PubMed ID: 1670637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+mice.
    Hosaka N; Nose M; Kyogoku M; Nagata N; Miyashima S; Good RA; Ikehara S
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8558-62. PubMed ID: 8710909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.